💔 Jesy Nelson has shared an emotional update that is both a triumph and a reminder of the long road ahead in her fight for Spinal Muscular Atrophy (SMA) screening. This milestone comes with mixed emotions as it marks a significant step forward—but also raises critical questions about the inequality in access to life-saving tests for newborns. 😔
In a heartfelt post, Jesy revealed that the rollout of newborn SMA screening will begin earlier than initially planned—October 2026, a full year ahead of the original target date of 2027. For many, this is a long-overdue breakthrough, but for Jesy, it’s personal. 💬 “This is something very close to my heart,” Jesy shared, thanking her supporters for helping elevate this important cause into the spotlight. 🙏
:max_bytes(150000):strip_icc():focal(999x0:1001x2)/jesy-nelson-zion-foster-baby-girls-092625-47a44031c14e45d3a9194def16b4eb43.jpg)
A PERSONAL BATTLE THAT SPARKED NATIONAL CHANGE
SMA is a rare genetic disorder that causes severe muscle weakness and, in its most extreme cases, can be life-limiting. Early diagnosis is essential in managing the condition, and timely intervention can be the difference between life-altering outcomes and potentially life-saving treatment.
Jesy’s battle began with a deeply personal tragedy—her twins, Ocean and Story, were diagnosed with SMA, sparking her tireless campaign. What started as a mother’s quest for answers soon grew into a national conversation about newborn screening, access to care, and the critical gaps within the NHS system.
Her petition, supported by thousands, has now reached the stage of a parliamentary debate, propelling it from a personal fight into a political priority. But, despite this victory, the work is far from over. 🏛️
PROGRESS – BUT NOT FOR EVERYONE
:max_bytes(150000):strip_icc():focal(749x0:751x2)/Jesy-Nelson-Twins-020426-999bab4252374c0aac681a07df01e461.jpg)
The announcement of earlier screening is a breakthrough—but not for everyone. The rollout will begin in selected areas only, which some have described as a “postcode lottery”. Critics have pointed out that babies born in certain regions will have access to early screening, while others may miss out completely, simply due to where they live.
For a condition where every minute counts, this disparity could be life-or-death. 💔 Jesy acknowledged the bittersweet nature of the announcement, calling it a huge step forward—but also highlighting that “there’s still so much more to do.”
THE POWER OF CELEBRITY CAMPAIGNING
Jesy’s story isn’t just about a celebrity raising awareness—it’s a testament to the real-world power of celebrity campaigning. By sharing her family’s journey, Jesy has brought SMA into the mainstream conversation, forcing both the public and policymakers to pay attention to a condition that was once relatively unknown. 📢
Her voice has been pivotal in shifting the conversation, but it also raises a question: should it take a high-profile figure to push for something as fundamental as newborn screening? 🤔
A WIN – WITH A WARNING

There is no denying that this is a victory. Early screening will undoubtedly save lives, improve outcomes, and offer families the clarity they so desperately need. However, as Jesy pointed out, it’s not the finish line.
“Until every baby has access to the same test at birth, the fight isn’t over,” Jesy said. She continued, “We’re getting closer,” a sentiment that offers hope but also reminds us of the work that still lies ahead. 🌟
For now, Jesy and her supporters are celebrating the progress made, but for many families, “closer” still isn’t soon enough. 🚨
Let’s continue to stand with Jesy as the fight for equality in SMA screening moves forward. 💪❤️


